Experts offer insights to summarize company-sponsored medical research for better understanding by patients and other audiences New study features stakeholder perspectives to inform best practices for developing easy-to-understand summaries of pharmaceutical...
Medical publication policies and guidelines offer a framework for best practices, but there may be situations when more than one approach seems reasonable. The primary purpose of “What Would You Do?” is to explore examples of such situations. With the limited...
Dave Andrews, Meridian HealthComms; Guy Yeoman, Mallinckrodt Pharmaceuticals; Tom Grant, UCB; Catherine Skobe, Pfizer This article is derived from a plenary session delivered at the 17th Annual Meeting of ISMPP, April 12-14, 2021. In any relationship, whether business...
ISMPP is honored to be featured in an upcoming episode of Advancements with Ted Danson, scheduled for broadcast in 1Q 2022. The Advancements television segment will present information about the medical publications profession and ISMPP’s role in establishing and...
Richa Chhabra, MS (Pharm), ISMPP CMPP™, Adelphi Communications Limited, UK; Sally Hassan, PhD, ISMPP CMPP™, UK; Lana Vegman, PharmD, ISMPP CMPP™, Novartis Pharmaceuticals, US What does a Medical Affairs team look like at a pharmaceutical/biotechnology company? Is it...
